Innovative Eyewear INC 8-K filings

Innovative Eyewear, Inc. announced the immediate exercise of existing warrants, generating approximately $3.0 million in gross proceeds and issuing new Series J warrants.

Innovative Eyewear, Inc. announced preliminary unaudited 2025 fiscal year sales growth of 65% and intent for management to purchase shares.

Innovative Eyewear, Inc. announced executive title changes, with Konrad Dabrowski moving to Chief AI and Growth Officer and Oswald Gayle becoming Chief Financial Officer.

Innovative Eyewear, Inc. stockholders approved a company name change to Lucyd, Inc., re-elected directors, and ratified the auditor and an extended rights plan, while rejecting the reinstatement of voting rights for certain control shares.

Innovative Eyewear, Inc. adjourned its annual stockholders' meeting to October 24, 2025, after failing to achieve a quorum required to transact business.

Innovative Eyewear, Inc. adjourned its annual stockholders meeting on August 26, 2025, due to a lack of quorum, rescheduling it for September 12, 2025.

Innovative Eyewear, Inc. increased the maximum shares available for sale under its At The Market offering to up to $2.68 million, as confirmed by a legal opinion.

Innovative Eyewear, Inc. announced the scheduled date for its 2025 Annual Meeting of Stockholders as August 26, 2025, and disclosed the deadline for director nominations.

Innovative Eyewear, Inc. announced it has raised approximately $4.8 million in gross proceeds through a warrant inducement transaction and additional ordinary course warrant exercises, aimed at bolstering working capital and general corporate purposes.

Innovative Eyewear, Inc. announces the exercise of outstanding warrants, generating $1.8 million in gross proceeds and the issuance of new unregistered Series G and H warrants.

Innovative Eyewear Inc. has appointed Oswald Gayle as Co-Chief Financial Officer, effective immediately, to also serve as Principal Financial and Accounting Officer.

Innovative Eyewear, Inc. has entered into agreements for the immediate exercise of outstanding warrants, generating approximately $2.6 million in gross proceeds and issuing new Series E and F warrants.

Innovative Eyewear has adopted a limited duration stockholder rights plan to protect shareholder value and prevent hostile takeovers.

Innovative Eyewear, Inc. has issued new Series C and D warrants to certain holders of existing warrants in exchange for the exercise of those existing warrants.

Innovative Eyewear, Inc. has entered into agreements for the immediate exercise of outstanding warrants, generating approximately $633,495 in gross proceeds and issuing new warrants.

Innovative Eyewear, Inc. has filed a prospectus supplement to increase the maximum number of shares issuable under its existing At-The-Market Offering Agreement.

Innovative Eyewear, Inc. has announced a 1-for-20 reverse stock split effective July 16, 2024, and the results of its annual shareholder meeting held on July 8, 2024.

Innovative Eyewear, Inc. has filed a prospectus supplement to increase the maximum number of shares issuable under its existing At-The-Market Offering Agreement.

Innovative Eyewear, Inc. has entered into a securities purchase agreement to raise approximately $2.5 million through a registered direct offering and concurrent private placement.

Innovative Eyewear, Inc. has entered into a securities purchase agreement to raise approximately $1 million through a registered direct offering and concurrent private placement of common stock and warrants.

Innovative Eyewear has temporarily suspended sales of its common stock under its At-The-Market Offering Agreement, pending the filing of a new prospectus supplement.

Innovative Eyewear, Inc. has entered into an agreement with H.C. Wainwright & Co., LLC to potentially sell up to $1,120,446 of its common stock through an at-the-market offering.